Global Contraceptive Injectable Market Growth 2026-2032
The global Contraceptive Injectable market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for Contraceptive Injectable is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Contraceptive Injectable is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Contraceptive Injectable is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Contraceptive Injectable players cover Bayer AG, China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu), Church & Dwight, Organon Group Of Companies, Pfizer Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Contraceptive Injectable Industry Forecast? looks at past sales and reviews total world Contraceptive Injectable sales in 2025, providing a comprehensive analysis by region and market sector of projected Contraceptive Injectable sales for 2026 through 2032. With Contraceptive Injectable sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Contraceptive Injectable industry.
This Insight Report provides a comprehensive analysis of the global Contraceptive Injectable landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Contraceptive Injectable portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Contraceptive Injectable market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Contraceptive Injectable and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Contraceptive Injectable.
This report presents a comprehensive overview, market shares, and growth opportunities of Contraceptive Injectable market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
United States market for Contraceptive Injectable is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Contraceptive Injectable is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Contraceptive Injectable is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Contraceptive Injectable players cover Bayer AG, China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu), Church & Dwight, Organon Group Of Companies, Pfizer Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Contraceptive Injectable Industry Forecast? looks at past sales and reviews total world Contraceptive Injectable sales in 2025, providing a comprehensive analysis by region and market sector of projected Contraceptive Injectable sales for 2026 through 2032. With Contraceptive Injectable sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Contraceptive Injectable industry.
This Insight Report provides a comprehensive analysis of the global Contraceptive Injectable landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Contraceptive Injectable portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Contraceptive Injectable market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Contraceptive Injectable and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Contraceptive Injectable.
This report presents a comprehensive overview, market shares, and growth opportunities of Contraceptive Injectable market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Long-Acting Contraception
- Short-Acting Contraception
- Male
- Female
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bayer AG
- China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu)
- Church & Dwight
- Organon Group Of Companies
- Pfizer Inc.
- Afaxys, Inc.
- Agile Therapeutics
- Janssen Pharmaceuticals, Inc.
- Veru, Inc.
- What is the 10-year outlook for the global Contraceptive Injectable market?
- What factors are driving Contraceptive Injectable market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Contraceptive Injectable market opportunities vary by end market size?
- How does Contraceptive Injectable break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Contraceptive Injectable Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Contraceptive Injectable by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Contraceptive Injectable by Country/Region, 2021, 2025 & 2032
2.2 Contraceptive Injectable Segment by Type
2.2.1 Long-Acting Contraception
2.2.2 Short-Acting Contraception
2.2.3 Contraceptive Injectable Sales by Type
2.2.3.1 Global Contraceptive Injectable Sales Market Share by Type (2021-2026)
2.2.3.2 Global Contraceptive Injectable Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Contraceptive Injectable Sale Price by Type (2021-2026)
2.3 Contraceptive Injectable Segment by Application
2.3.1 Male
2.3.2 Female
2.3.3 Contraceptive Injectable Sales by Application
2.3.3.1 Global Contraceptive Injectable Sale Market Share by Application (2021-2026)
2.3.3.2 Global Contraceptive Injectable Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Contraceptive Injectable Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Contraceptive Injectable Breakdown Data by Company
3.1.1 Global Contraceptive Injectable Annual Sales by Company (2021-2026)
3.1.2 Global Contraceptive Injectable Sales Market Share by Company (2021-2026)
3.2 Global Contraceptive Injectable Annual Revenue by Company (2021-2026)
3.2.1 Global Contraceptive Injectable Revenue by Company (2021-2026)
3.2.2 Global Contraceptive Injectable Revenue Market Share by Company (2021-2026)
3.3 Global Contraceptive Injectable Sale Price by Company
3.4 Key Manufacturers Contraceptive Injectable Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Contraceptive Injectable Product Location Distribution
3.4.2 Players Contraceptive Injectable Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CONTRACEPTIVE INJECTABLE BY GEOGRAPHIC REGION
4.1 World Historic Contraceptive Injectable Market Size by Geographic Region (2021-2026)
4.1.1 Global Contraceptive Injectable Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Contraceptive Injectable Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Contraceptive Injectable Market Size by Country/Region (2021-2026)
4.2.1 Global Contraceptive Injectable Annual Sales by Country/Region (2021-2026)
4.2.2 Global Contraceptive Injectable Annual Revenue by Country/Region (2021-2026)
4.3 Americas Contraceptive Injectable Sales Growth
4.4 APAC Contraceptive Injectable Sales Growth
4.5 Europe Contraceptive Injectable Sales Growth
4.6 Middle East & Africa Contraceptive Injectable Sales Growth
5 AMERICAS
5.1 Americas Contraceptive Injectable Sales by Country
5.1.1 Americas Contraceptive Injectable Sales by Country (2021-2026)
5.1.2 Americas Contraceptive Injectable Revenue by Country (2021-2026)
5.2 Americas Contraceptive Injectable Sales by Type (2021-2026)
5.3 Americas Contraceptive Injectable Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Contraceptive Injectable Sales by Region
6.1.1 APAC Contraceptive Injectable Sales by Region (2021-2026)
6.1.2 APAC Contraceptive Injectable Revenue by Region (2021-2026)
6.2 APAC Contraceptive Injectable Sales by Type (2021-2026)
6.3 APAC Contraceptive Injectable Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Contraceptive Injectable by Country
7.1.1 Europe Contraceptive Injectable Sales by Country (2021-2026)
7.1.2 Europe Contraceptive Injectable Revenue by Country (2021-2026)
7.2 Europe Contraceptive Injectable Sales by Type (2021-2026)
7.3 Europe Contraceptive Injectable Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Contraceptive Injectable by Country
8.1.1 Middle East & Africa Contraceptive Injectable Sales by Country (2021-2026)
8.1.2 Middle East & Africa Contraceptive Injectable Revenue by Country (2021-2026)
8.2 Middle East & Africa Contraceptive Injectable Sales by Type (2021-2026)
8.3 Middle East & Africa Contraceptive Injectable Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Contraceptive Injectable
10.3 Manufacturing Process Analysis of Contraceptive Injectable
10.4 Industry Chain Structure of Contraceptive Injectable
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Contraceptive Injectable Distributors
11.3 Contraceptive Injectable Customer
12 WORLD FORECAST REVIEW FOR CONTRACEPTIVE INJECTABLE BY GEOGRAPHIC REGION
12.1 Global Contraceptive Injectable Market Size Forecast by Region
12.1.1 Global Contraceptive Injectable Forecast by Region (2027-2032)
12.1.2 Global Contraceptive Injectable Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Contraceptive Injectable Forecast by Type (2027-2032)
12.7 Global Contraceptive Injectable Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Bayer AG
13.1.1 Bayer AG Company Information
13.1.2 Bayer AG Contraceptive Injectable Product Portfolios and Specifications
13.1.3 Bayer AG Contraceptive Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Bayer AG Main Business Overview
13.1.5 Bayer AG Latest Developments
13.2 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu)
13.2.1 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Company Information
13.2.2 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Contraceptive Injectable Product Portfolios and Specifications
13.2.3 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Contraceptive Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Main Business Overview
13.2.5 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Latest Developments
13.3 Church & Dwight
13.3.1 Church & Dwight Company Information
13.3.2 Church & Dwight Contraceptive Injectable Product Portfolios and Specifications
13.3.3 Church & Dwight Contraceptive Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Church & Dwight Main Business Overview
13.3.5 Church & Dwight Latest Developments
13.4 Organon Group Of Companies
13.4.1 Organon Group Of Companies Company Information
13.4.2 Organon Group Of Companies Contraceptive Injectable Product Portfolios and Specifications
13.4.3 Organon Group Of Companies Contraceptive Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Organon Group Of Companies Main Business Overview
13.4.5 Organon Group Of Companies Latest Developments
13.5 Pfizer Inc.
13.5.1 Pfizer Inc. Company Information
13.5.2 Pfizer Inc. Contraceptive Injectable Product Portfolios and Specifications
13.5.3 Pfizer Inc. Contraceptive Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Pfizer Inc. Main Business Overview
13.5.5 Pfizer Inc. Latest Developments
13.6 Afaxys, Inc.
13.6.1 Afaxys, Inc. Company Information
13.6.2 Afaxys, Inc. Contraceptive Injectable Product Portfolios and Specifications
13.6.3 Afaxys, Inc. Contraceptive Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Afaxys, Inc. Main Business Overview
13.6.5 Afaxys, Inc. Latest Developments
13.7 Agile Therapeutics
13.7.1 Agile Therapeutics Company Information
13.7.2 Agile Therapeutics Contraceptive Injectable Product Portfolios and Specifications
13.7.3 Agile Therapeutics Contraceptive Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Agile Therapeutics Main Business Overview
13.7.5 Agile Therapeutics Latest Developments
13.8 Janssen Pharmaceuticals, Inc.
13.8.1 Janssen Pharmaceuticals, Inc. Company Information
13.8.2 Janssen Pharmaceuticals, Inc. Contraceptive Injectable Product Portfolios and Specifications
13.8.3 Janssen Pharmaceuticals, Inc. Contraceptive Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Janssen Pharmaceuticals, Inc. Main Business Overview
13.8.5 Janssen Pharmaceuticals, Inc. Latest Developments
13.9 Veru, Inc.
13.9.1 Veru, Inc. Company Information
13.9.2 Veru, Inc. Contraceptive Injectable Product Portfolios and Specifications
13.9.3 Veru, Inc. Contraceptive Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Veru, Inc. Main Business Overview
13.9.5 Veru, Inc. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Contraceptive Injectable Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Contraceptive Injectable by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Contraceptive Injectable by Country/Region, 2021, 2025 & 2032
2.2 Contraceptive Injectable Segment by Type
2.2.1 Long-Acting Contraception
2.2.2 Short-Acting Contraception
2.2.3 Contraceptive Injectable Sales by Type
2.2.3.1 Global Contraceptive Injectable Sales Market Share by Type (2021-2026)
2.2.3.2 Global Contraceptive Injectable Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Contraceptive Injectable Sale Price by Type (2021-2026)
2.3 Contraceptive Injectable Segment by Application
2.3.1 Male
2.3.2 Female
2.3.3 Contraceptive Injectable Sales by Application
2.3.3.1 Global Contraceptive Injectable Sale Market Share by Application (2021-2026)
2.3.3.2 Global Contraceptive Injectable Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Contraceptive Injectable Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Contraceptive Injectable Breakdown Data by Company
3.1.1 Global Contraceptive Injectable Annual Sales by Company (2021-2026)
3.1.2 Global Contraceptive Injectable Sales Market Share by Company (2021-2026)
3.2 Global Contraceptive Injectable Annual Revenue by Company (2021-2026)
3.2.1 Global Contraceptive Injectable Revenue by Company (2021-2026)
3.2.2 Global Contraceptive Injectable Revenue Market Share by Company (2021-2026)
3.3 Global Contraceptive Injectable Sale Price by Company
3.4 Key Manufacturers Contraceptive Injectable Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Contraceptive Injectable Product Location Distribution
3.4.2 Players Contraceptive Injectable Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CONTRACEPTIVE INJECTABLE BY GEOGRAPHIC REGION
4.1 World Historic Contraceptive Injectable Market Size by Geographic Region (2021-2026)
4.1.1 Global Contraceptive Injectable Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Contraceptive Injectable Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Contraceptive Injectable Market Size by Country/Region (2021-2026)
4.2.1 Global Contraceptive Injectable Annual Sales by Country/Region (2021-2026)
4.2.2 Global Contraceptive Injectable Annual Revenue by Country/Region (2021-2026)
4.3 Americas Contraceptive Injectable Sales Growth
4.4 APAC Contraceptive Injectable Sales Growth
4.5 Europe Contraceptive Injectable Sales Growth
4.6 Middle East & Africa Contraceptive Injectable Sales Growth
5 AMERICAS
5.1 Americas Contraceptive Injectable Sales by Country
5.1.1 Americas Contraceptive Injectable Sales by Country (2021-2026)
5.1.2 Americas Contraceptive Injectable Revenue by Country (2021-2026)
5.2 Americas Contraceptive Injectable Sales by Type (2021-2026)
5.3 Americas Contraceptive Injectable Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Contraceptive Injectable Sales by Region
6.1.1 APAC Contraceptive Injectable Sales by Region (2021-2026)
6.1.2 APAC Contraceptive Injectable Revenue by Region (2021-2026)
6.2 APAC Contraceptive Injectable Sales by Type (2021-2026)
6.3 APAC Contraceptive Injectable Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Contraceptive Injectable by Country
7.1.1 Europe Contraceptive Injectable Sales by Country (2021-2026)
7.1.2 Europe Contraceptive Injectable Revenue by Country (2021-2026)
7.2 Europe Contraceptive Injectable Sales by Type (2021-2026)
7.3 Europe Contraceptive Injectable Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Contraceptive Injectable by Country
8.1.1 Middle East & Africa Contraceptive Injectable Sales by Country (2021-2026)
8.1.2 Middle East & Africa Contraceptive Injectable Revenue by Country (2021-2026)
8.2 Middle East & Africa Contraceptive Injectable Sales by Type (2021-2026)
8.3 Middle East & Africa Contraceptive Injectable Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Contraceptive Injectable
10.3 Manufacturing Process Analysis of Contraceptive Injectable
10.4 Industry Chain Structure of Contraceptive Injectable
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Contraceptive Injectable Distributors
11.3 Contraceptive Injectable Customer
12 WORLD FORECAST REVIEW FOR CONTRACEPTIVE INJECTABLE BY GEOGRAPHIC REGION
12.1 Global Contraceptive Injectable Market Size Forecast by Region
12.1.1 Global Contraceptive Injectable Forecast by Region (2027-2032)
12.1.2 Global Contraceptive Injectable Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Contraceptive Injectable Forecast by Type (2027-2032)
12.7 Global Contraceptive Injectable Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Bayer AG
13.1.1 Bayer AG Company Information
13.1.2 Bayer AG Contraceptive Injectable Product Portfolios and Specifications
13.1.3 Bayer AG Contraceptive Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Bayer AG Main Business Overview
13.1.5 Bayer AG Latest Developments
13.2 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu)
13.2.1 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Company Information
13.2.2 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Contraceptive Injectable Product Portfolios and Specifications
13.2.3 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Contraceptive Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Main Business Overview
13.2.5 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Latest Developments
13.3 Church & Dwight
13.3.1 Church & Dwight Company Information
13.3.2 Church & Dwight Contraceptive Injectable Product Portfolios and Specifications
13.3.3 Church & Dwight Contraceptive Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Church & Dwight Main Business Overview
13.3.5 Church & Dwight Latest Developments
13.4 Organon Group Of Companies
13.4.1 Organon Group Of Companies Company Information
13.4.2 Organon Group Of Companies Contraceptive Injectable Product Portfolios and Specifications
13.4.3 Organon Group Of Companies Contraceptive Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Organon Group Of Companies Main Business Overview
13.4.5 Organon Group Of Companies Latest Developments
13.5 Pfizer Inc.
13.5.1 Pfizer Inc. Company Information
13.5.2 Pfizer Inc. Contraceptive Injectable Product Portfolios and Specifications
13.5.3 Pfizer Inc. Contraceptive Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Pfizer Inc. Main Business Overview
13.5.5 Pfizer Inc. Latest Developments
13.6 Afaxys, Inc.
13.6.1 Afaxys, Inc. Company Information
13.6.2 Afaxys, Inc. Contraceptive Injectable Product Portfolios and Specifications
13.6.3 Afaxys, Inc. Contraceptive Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Afaxys, Inc. Main Business Overview
13.6.5 Afaxys, Inc. Latest Developments
13.7 Agile Therapeutics
13.7.1 Agile Therapeutics Company Information
13.7.2 Agile Therapeutics Contraceptive Injectable Product Portfolios and Specifications
13.7.3 Agile Therapeutics Contraceptive Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Agile Therapeutics Main Business Overview
13.7.5 Agile Therapeutics Latest Developments
13.8 Janssen Pharmaceuticals, Inc.
13.8.1 Janssen Pharmaceuticals, Inc. Company Information
13.8.2 Janssen Pharmaceuticals, Inc. Contraceptive Injectable Product Portfolios and Specifications
13.8.3 Janssen Pharmaceuticals, Inc. Contraceptive Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Janssen Pharmaceuticals, Inc. Main Business Overview
13.8.5 Janssen Pharmaceuticals, Inc. Latest Developments
13.9 Veru, Inc.
13.9.1 Veru, Inc. Company Information
13.9.2 Veru, Inc. Contraceptive Injectable Product Portfolios and Specifications
13.9.3 Veru, Inc. Contraceptive Injectable Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Veru, Inc. Main Business Overview
13.9.5 Veru, Inc. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Contraceptive Injectable Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Contraceptive Injectable Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Long-Acting Contraception
Table 4. Major Players of Short-Acting Contraception
Table 5. Global Contraceptive Injectable Sales by Type (2021-2026) & (K Units)
Table 6. Global Contraceptive Injectable Sales Market Share by Type (2021-2026)
Table 7. Global Contraceptive Injectable Revenue by Type (2021-2026) & ($ million)
Table 8. Global Contraceptive Injectable Revenue Market Share by Type (2021-2026)
Table 9. Global Contraceptive Injectable Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Contraceptive Injectable Sale by Application (2021-2026) & (K Units)
Table 11. Global Contraceptive Injectable Sale Market Share by Application (2021-2026)
Table 12. Global Contraceptive Injectable Revenue by Application (2021-2026) & ($ million)
Table 13. Global Contraceptive Injectable Revenue Market Share by Application (2021-2026)
Table 14. Global Contraceptive Injectable Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Contraceptive Injectable Sales by Company (2021-2026) & (K Units)
Table 16. Global Contraceptive Injectable Sales Market Share by Company (2021-2026)
Table 17. Global Contraceptive Injectable Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Contraceptive Injectable Revenue Market Share by Company (2021-2026)
Table 19. Global Contraceptive Injectable Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Contraceptive Injectable Producing Area Distribution and Sales Area
Table 21. Players Contraceptive Injectable Products Offered
Table 22. Contraceptive Injectable Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Contraceptive Injectable Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Contraceptive Injectable Sales Market Share Geographic Region (2021-2026)
Table 27. Global Contraceptive Injectable Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Contraceptive Injectable Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Contraceptive Injectable Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Contraceptive Injectable Sales Market Share by Country/Region (2021-2026)
Table 31. Global Contraceptive Injectable Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Contraceptive Injectable Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Contraceptive Injectable Sales by Country (2021-2026) & (K Units)
Table 34. Americas Contraceptive Injectable Sales Market Share by Country (2021-2026)
Table 35. Americas Contraceptive Injectable Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Contraceptive Injectable Sales by Type (2021-2026) & (K Units)
Table 37. Americas Contraceptive Injectable Sales by Application (2021-2026) & (K Units)
Table 38. APAC Contraceptive Injectable Sales by Region (2021-2026) & (K Units)
Table 39. APAC Contraceptive Injectable Sales Market Share by Region (2021-2026)
Table 40. APAC Contraceptive Injectable Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Contraceptive Injectable Sales by Type (2021-2026) & (K Units)
Table 42. APAC Contraceptive Injectable Sales by Application (2021-2026) & (K Units)
Table 43. Europe Contraceptive Injectable Sales by Country (2021-2026) & (K Units)
Table 44. Europe Contraceptive Injectable Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Contraceptive Injectable Sales by Type (2021-2026) & (K Units)
Table 46. Europe Contraceptive Injectable Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Contraceptive Injectable Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Contraceptive Injectable Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Contraceptive Injectable Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Contraceptive Injectable Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Contraceptive Injectable
Table 52. Key Market Challenges & Risks of Contraceptive Injectable
Table 53. Key Industry Trends of Contraceptive Injectable
Table 54. Contraceptive Injectable Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Contraceptive Injectable Distributors List
Table 57. Contraceptive Injectable Customer List
Table 58. Global Contraceptive Injectable Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Contraceptive Injectable Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Contraceptive Injectable Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Contraceptive Injectable Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Contraceptive Injectable Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Contraceptive Injectable Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Contraceptive Injectable Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Contraceptive Injectable Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Contraceptive Injectable Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Contraceptive Injectable Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Contraceptive Injectable Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Contraceptive Injectable Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Contraceptive Injectable Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Contraceptive Injectable Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Bayer AG Basic Information, Contraceptive Injectable Manufacturing Base, Sales Area and Its Competitors
Table 73. Bayer AG Contraceptive Injectable Product Portfolios and Specifications
Table 74. Bayer AG Contraceptive Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Bayer AG Main Business
Table 76. Bayer AG Latest Developments
Table 77. China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Basic Information, Contraceptive Injectable Manufacturing Base, Sales Area and Its Competitors
Table 78. China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Contraceptive Injectable Product Portfolios and Specifications
Table 79. China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Contraceptive Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Main Business
Table 81. China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Latest Developments
Table 82. Church & Dwight Basic Information, Contraceptive Injectable Manufacturing Base, Sales Area and Its Competitors
Table 83. Church & Dwight Contraceptive Injectable Product Portfolios and Specifications
Table 84. Church & Dwight Contraceptive Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Church & Dwight Main Business
Table 86. Church & Dwight Latest Developments
Table 87. Organon Group Of Companies Basic Information, Contraceptive Injectable Manufacturing Base, Sales Area and Its Competitors
Table 88. Organon Group Of Companies Contraceptive Injectable Product Portfolios and Specifications
Table 89. Organon Group Of Companies Contraceptive Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Organon Group Of Companies Main Business
Table 91. Organon Group Of Companies Latest Developments
Table 92. Pfizer Inc. Basic Information, Contraceptive Injectable Manufacturing Base, Sales Area and Its Competitors
Table 93. Pfizer Inc. Contraceptive Injectable Product Portfolios and Specifications
Table 94. Pfizer Inc. Contraceptive Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Pfizer Inc. Main Business
Table 96. Pfizer Inc. Latest Developments
Table 97. Afaxys, Inc. Basic Information, Contraceptive Injectable Manufacturing Base, Sales Area and Its Competitors
Table 98. Afaxys, Inc. Contraceptive Injectable Product Portfolios and Specifications
Table 99. Afaxys, Inc. Contraceptive Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Afaxys, Inc. Main Business
Table 101. Afaxys, Inc. Latest Developments
Table 102. Agile Therapeutics Basic Information, Contraceptive Injectable Manufacturing Base, Sales Area and Its Competitors
Table 103. Agile Therapeutics Contraceptive Injectable Product Portfolios and Specifications
Table 104. Agile Therapeutics Contraceptive Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Agile Therapeutics Main Business
Table 106. Agile Therapeutics Latest Developments
Table 107. Janssen Pharmaceuticals, Inc. Basic Information, Contraceptive Injectable Manufacturing Base, Sales Area and Its Competitors
Table 108. Janssen Pharmaceuticals, Inc. Contraceptive Injectable Product Portfolios and Specifications
Table 109. Janssen Pharmaceuticals, Inc. Contraceptive Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Janssen Pharmaceuticals, Inc. Main Business
Table 111. Janssen Pharmaceuticals, Inc. Latest Developments
Table 112. Veru, Inc. Basic Information, Contraceptive Injectable Manufacturing Base, Sales Area and Its Competitors
Table 113. Veru, Inc. Contraceptive Injectable Product Portfolios and Specifications
Table 114. Veru, Inc. Contraceptive Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Veru, Inc. Main Business
Table 116. Veru, Inc. Latest Developments
Table 1. Contraceptive Injectable Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Contraceptive Injectable Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Long-Acting Contraception
Table 4. Major Players of Short-Acting Contraception
Table 5. Global Contraceptive Injectable Sales by Type (2021-2026) & (K Units)
Table 6. Global Contraceptive Injectable Sales Market Share by Type (2021-2026)
Table 7. Global Contraceptive Injectable Revenue by Type (2021-2026) & ($ million)
Table 8. Global Contraceptive Injectable Revenue Market Share by Type (2021-2026)
Table 9. Global Contraceptive Injectable Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Contraceptive Injectable Sale by Application (2021-2026) & (K Units)
Table 11. Global Contraceptive Injectable Sale Market Share by Application (2021-2026)
Table 12. Global Contraceptive Injectable Revenue by Application (2021-2026) & ($ million)
Table 13. Global Contraceptive Injectable Revenue Market Share by Application (2021-2026)
Table 14. Global Contraceptive Injectable Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Contraceptive Injectable Sales by Company (2021-2026) & (K Units)
Table 16. Global Contraceptive Injectable Sales Market Share by Company (2021-2026)
Table 17. Global Contraceptive Injectable Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Contraceptive Injectable Revenue Market Share by Company (2021-2026)
Table 19. Global Contraceptive Injectable Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Contraceptive Injectable Producing Area Distribution and Sales Area
Table 21. Players Contraceptive Injectable Products Offered
Table 22. Contraceptive Injectable Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Contraceptive Injectable Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Contraceptive Injectable Sales Market Share Geographic Region (2021-2026)
Table 27. Global Contraceptive Injectable Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Contraceptive Injectable Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Contraceptive Injectable Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Contraceptive Injectable Sales Market Share by Country/Region (2021-2026)
Table 31. Global Contraceptive Injectable Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Contraceptive Injectable Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Contraceptive Injectable Sales by Country (2021-2026) & (K Units)
Table 34. Americas Contraceptive Injectable Sales Market Share by Country (2021-2026)
Table 35. Americas Contraceptive Injectable Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Contraceptive Injectable Sales by Type (2021-2026) & (K Units)
Table 37. Americas Contraceptive Injectable Sales by Application (2021-2026) & (K Units)
Table 38. APAC Contraceptive Injectable Sales by Region (2021-2026) & (K Units)
Table 39. APAC Contraceptive Injectable Sales Market Share by Region (2021-2026)
Table 40. APAC Contraceptive Injectable Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Contraceptive Injectable Sales by Type (2021-2026) & (K Units)
Table 42. APAC Contraceptive Injectable Sales by Application (2021-2026) & (K Units)
Table 43. Europe Contraceptive Injectable Sales by Country (2021-2026) & (K Units)
Table 44. Europe Contraceptive Injectable Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Contraceptive Injectable Sales by Type (2021-2026) & (K Units)
Table 46. Europe Contraceptive Injectable Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Contraceptive Injectable Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Contraceptive Injectable Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Contraceptive Injectable Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Contraceptive Injectable Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Contraceptive Injectable
Table 52. Key Market Challenges & Risks of Contraceptive Injectable
Table 53. Key Industry Trends of Contraceptive Injectable
Table 54. Contraceptive Injectable Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Contraceptive Injectable Distributors List
Table 57. Contraceptive Injectable Customer List
Table 58. Global Contraceptive Injectable Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Contraceptive Injectable Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Contraceptive Injectable Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Contraceptive Injectable Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Contraceptive Injectable Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Contraceptive Injectable Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Contraceptive Injectable Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Contraceptive Injectable Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Contraceptive Injectable Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Contraceptive Injectable Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Contraceptive Injectable Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Contraceptive Injectable Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Contraceptive Injectable Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Contraceptive Injectable Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Bayer AG Basic Information, Contraceptive Injectable Manufacturing Base, Sales Area and Its Competitors
Table 73. Bayer AG Contraceptive Injectable Product Portfolios and Specifications
Table 74. Bayer AG Contraceptive Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Bayer AG Main Business
Table 76. Bayer AG Latest Developments
Table 77. China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Basic Information, Contraceptive Injectable Manufacturing Base, Sales Area and Its Competitors
Table 78. China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Contraceptive Injectable Product Portfolios and Specifications
Table 79. China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Contraceptive Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Main Business
Table 81. China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Latest Developments
Table 82. Church & Dwight Basic Information, Contraceptive Injectable Manufacturing Base, Sales Area and Its Competitors
Table 83. Church & Dwight Contraceptive Injectable Product Portfolios and Specifications
Table 84. Church & Dwight Contraceptive Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Church & Dwight Main Business
Table 86. Church & Dwight Latest Developments
Table 87. Organon Group Of Companies Basic Information, Contraceptive Injectable Manufacturing Base, Sales Area and Its Competitors
Table 88. Organon Group Of Companies Contraceptive Injectable Product Portfolios and Specifications
Table 89. Organon Group Of Companies Contraceptive Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Organon Group Of Companies Main Business
Table 91. Organon Group Of Companies Latest Developments
Table 92. Pfizer Inc. Basic Information, Contraceptive Injectable Manufacturing Base, Sales Area and Its Competitors
Table 93. Pfizer Inc. Contraceptive Injectable Product Portfolios and Specifications
Table 94. Pfizer Inc. Contraceptive Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Pfizer Inc. Main Business
Table 96. Pfizer Inc. Latest Developments
Table 97. Afaxys, Inc. Basic Information, Contraceptive Injectable Manufacturing Base, Sales Area and Its Competitors
Table 98. Afaxys, Inc. Contraceptive Injectable Product Portfolios and Specifications
Table 99. Afaxys, Inc. Contraceptive Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Afaxys, Inc. Main Business
Table 101. Afaxys, Inc. Latest Developments
Table 102. Agile Therapeutics Basic Information, Contraceptive Injectable Manufacturing Base, Sales Area and Its Competitors
Table 103. Agile Therapeutics Contraceptive Injectable Product Portfolios and Specifications
Table 104. Agile Therapeutics Contraceptive Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Agile Therapeutics Main Business
Table 106. Agile Therapeutics Latest Developments
Table 107. Janssen Pharmaceuticals, Inc. Basic Information, Contraceptive Injectable Manufacturing Base, Sales Area and Its Competitors
Table 108. Janssen Pharmaceuticals, Inc. Contraceptive Injectable Product Portfolios and Specifications
Table 109. Janssen Pharmaceuticals, Inc. Contraceptive Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Janssen Pharmaceuticals, Inc. Main Business
Table 111. Janssen Pharmaceuticals, Inc. Latest Developments
Table 112. Veru, Inc. Basic Information, Contraceptive Injectable Manufacturing Base, Sales Area and Its Competitors
Table 113. Veru, Inc. Contraceptive Injectable Product Portfolios and Specifications
Table 114. Veru, Inc. Contraceptive Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Veru, Inc. Main Business
Table 116. Veru, Inc. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Contraceptive Injectable
Figure 2. Contraceptive Injectable Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Contraceptive Injectable Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Contraceptive Injectable Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Contraceptive Injectable Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Contraceptive Injectable Sales Market Share by Country/Region (2025)
Figure 10. Contraceptive Injectable Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Long-Acting Contraception
Figure 12. Product Picture of Short-Acting Contraception
Figure 13. Global Contraceptive Injectable Sales Market Share by Type in 2026
Figure 14. Global Contraceptive Injectable Revenue Market Share by Type (2021-2026)
Figure 15. Contraceptive Injectable Consumed in Male
Figure 16. Global Contraceptive Injectable Market: Male (2021-2026) & (K Units)
Figure 17. Contraceptive Injectable Consumed in Female
Figure 18. Global Contraceptive Injectable Market: Female (2021-2026) & (K Units)
Figure 19. Global Contraceptive Injectable Sale Market Share by Application (2025)
Figure 20. Global Contraceptive Injectable Revenue Market Share by Application in 2026
Figure 21. Contraceptive Injectable Sales by Company in 2026 (K Units)
Figure 22. Global Contraceptive Injectable Sales Market Share by Company in 2026
Figure 23. Contraceptive Injectable Revenue by Company in 2026 ($ millions)
Figure 24. Global Contraceptive Injectable Revenue Market Share by Company in 2026
Figure 25. Global Contraceptive Injectable Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Contraceptive Injectable Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Contraceptive Injectable Sales 2021-2026 (K Units)
Figure 28. Americas Contraceptive Injectable Revenue 2021-2026 ($ millions)
Figure 29. APAC Contraceptive Injectable Sales 2021-2026 (K Units)
Figure 30. APAC Contraceptive Injectable Revenue 2021-2026 ($ millions)
Figure 31. Europe Contraceptive Injectable Sales 2021-2026 (K Units)
Figure 32. Europe Contraceptive Injectable Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Contraceptive Injectable Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Contraceptive Injectable Revenue 2021-2026 ($ millions)
Figure 35. Americas Contraceptive Injectable Sales Market Share by Country in 2026
Figure 36. Americas Contraceptive Injectable Revenue Market Share by Country (2021-2026)
Figure 37. Americas Contraceptive Injectable Sales Market Share by Type (2021-2026)
Figure 38. Americas Contraceptive Injectable Sales Market Share by Application (2021-2026)
Figure 39. United States Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Contraceptive Injectable Sales Market Share by Region in 2026
Figure 44. APAC Contraceptive Injectable Revenue Market Share by Region (2021-2026)
Figure 45. APAC Contraceptive Injectable Sales Market Share by Type (2021-2026)
Figure 46. APAC Contraceptive Injectable Sales Market Share by Application (2021-2026)
Figure 47. China Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 51. India Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Contraceptive Injectable Sales Market Share by Country in 2026
Figure 55. Europe Contraceptive Injectable Revenue Market Share by Country (2021-2026)
Figure 56. Europe Contraceptive Injectable Sales Market Share by Type (2021-2026)
Figure 57. Europe Contraceptive Injectable Sales Market Share by Application (2021-2026)
Figure 58. Germany Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 59. France Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Contraceptive Injectable Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Contraceptive Injectable Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Contraceptive Injectable Sales Market Share by Application (2021-2026)
Figure 66. Egypt Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Contraceptive Injectable in 2026
Figure 72. Manufacturing Process Analysis of Contraceptive Injectable
Figure 73. Industry Chain Structure of Contraceptive Injectable
Figure 74. Channels of Distribution
Figure 75. Global Contraceptive Injectable Sales Market Forecast by Region (2027-2032)
Figure 76. Global Contraceptive Injectable Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Contraceptive Injectable Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Contraceptive Injectable Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Contraceptive Injectable Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Contraceptive Injectable Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Contraceptive Injectable
Figure 2. Contraceptive Injectable Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Contraceptive Injectable Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Contraceptive Injectable Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Contraceptive Injectable Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Contraceptive Injectable Sales Market Share by Country/Region (2025)
Figure 10. Contraceptive Injectable Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Long-Acting Contraception
Figure 12. Product Picture of Short-Acting Contraception
Figure 13. Global Contraceptive Injectable Sales Market Share by Type in 2026
Figure 14. Global Contraceptive Injectable Revenue Market Share by Type (2021-2026)
Figure 15. Contraceptive Injectable Consumed in Male
Figure 16. Global Contraceptive Injectable Market: Male (2021-2026) & (K Units)
Figure 17. Contraceptive Injectable Consumed in Female
Figure 18. Global Contraceptive Injectable Market: Female (2021-2026) & (K Units)
Figure 19. Global Contraceptive Injectable Sale Market Share by Application (2025)
Figure 20. Global Contraceptive Injectable Revenue Market Share by Application in 2026
Figure 21. Contraceptive Injectable Sales by Company in 2026 (K Units)
Figure 22. Global Contraceptive Injectable Sales Market Share by Company in 2026
Figure 23. Contraceptive Injectable Revenue by Company in 2026 ($ millions)
Figure 24. Global Contraceptive Injectable Revenue Market Share by Company in 2026
Figure 25. Global Contraceptive Injectable Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Contraceptive Injectable Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Contraceptive Injectable Sales 2021-2026 (K Units)
Figure 28. Americas Contraceptive Injectable Revenue 2021-2026 ($ millions)
Figure 29. APAC Contraceptive Injectable Sales 2021-2026 (K Units)
Figure 30. APAC Contraceptive Injectable Revenue 2021-2026 ($ millions)
Figure 31. Europe Contraceptive Injectable Sales 2021-2026 (K Units)
Figure 32. Europe Contraceptive Injectable Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Contraceptive Injectable Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Contraceptive Injectable Revenue 2021-2026 ($ millions)
Figure 35. Americas Contraceptive Injectable Sales Market Share by Country in 2026
Figure 36. Americas Contraceptive Injectable Revenue Market Share by Country (2021-2026)
Figure 37. Americas Contraceptive Injectable Sales Market Share by Type (2021-2026)
Figure 38. Americas Contraceptive Injectable Sales Market Share by Application (2021-2026)
Figure 39. United States Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Contraceptive Injectable Sales Market Share by Region in 2026
Figure 44. APAC Contraceptive Injectable Revenue Market Share by Region (2021-2026)
Figure 45. APAC Contraceptive Injectable Sales Market Share by Type (2021-2026)
Figure 46. APAC Contraceptive Injectable Sales Market Share by Application (2021-2026)
Figure 47. China Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 51. India Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Contraceptive Injectable Sales Market Share by Country in 2026
Figure 55. Europe Contraceptive Injectable Revenue Market Share by Country (2021-2026)
Figure 56. Europe Contraceptive Injectable Sales Market Share by Type (2021-2026)
Figure 57. Europe Contraceptive Injectable Sales Market Share by Application (2021-2026)
Figure 58. Germany Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 59. France Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Contraceptive Injectable Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Contraceptive Injectable Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Contraceptive Injectable Sales Market Share by Application (2021-2026)
Figure 66. Egypt Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Contraceptive Injectable Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Contraceptive Injectable in 2026
Figure 72. Manufacturing Process Analysis of Contraceptive Injectable
Figure 73. Industry Chain Structure of Contraceptive Injectable
Figure 74. Channels of Distribution
Figure 75. Global Contraceptive Injectable Sales Market Forecast by Region (2027-2032)
Figure 76. Global Contraceptive Injectable Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Contraceptive Injectable Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Contraceptive Injectable Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Contraceptive Injectable Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Contraceptive Injectable Revenue Market Share Forecast by Application (2027-2032)
